Needle-free immunizations

December 01, 2005

Santa Barbara, California - December 1, 2005 -- Samir Mitragotri, a professor of chemical engineering at the University of California, Santa Barbara, says the myriad shortcomings of injections have led to active research and development of needle-free methods of immunization. While most people prefer to avoid injections, the stakes are enormously higher than just helping people avoid a disagreeable prick of a needle. In third world countries, improper and unsafe use of the needles used in injections causes millions of cases of hepatitis B and hepatitis C, and thousands of HIV infections. The World Health Organization has estimated that as many as one-third of immunization injections are unsafe in four of it six geographical regions.

In a paper published today in Nature Reviews, "Immunization Without Needles," Mitragotri reviews in detail the characteristics - and pros and cons - of the currently available methods of immunization, which include topical application to the skin, pills, nasal sprays, injections, and others. Considerable advances have been made in the past decade, especially in transdermal (through the skin) and nasal immunization.

"Unfortunately, because of the development costs of new immunization methods, use of needle-free immunization might initially push the direct cost of immunizations higher," says Mitragotri. "But the secondary costs of needle-based immunization - infection and disease - are high and could be prevented with needle-free methods." Mitragotri says that he anticipates that needle-free methods will reduce the economic burden associated with needle-caused infections, eventually proving to be economically feasible.

A wide range of interdisciplinary researchers and businesses are focusing on needle-free immunization delivery methods, says Mitragotri, helping ensure that needle-free immunizations will eventually be commonly used.
-end-
Media Contact: Barbara B. Gray 818.889.5415 bbgray@sbcglobal.net

Samir Mitragotri: samir@engineering.ucsb.edu

University of California - Santa Barbara

Related Immunization Articles from Brightsurf:

Safety of HPV vaccines in males
A new analysis published in the British Journal of Clinical Pharmacology shows that HPV vaccines are safe and well tolerated in the male population, and the side effects that may occur after immunization are similar in both sexes.

Key populations for early COVID-19 immunization in Canada
Canada's National Advisory Committee on Immunization (NACI) recommends vaccinating key populations, such as people at risk of severe illness or death, those at risk of transmitting the virus and essential workers, during the initial rollout of a COVID-19 vaccine in Canada.

Malaria vaccine trial samples reveal immune benchmarks for achieving protection
By studying samples from two independent clinical trials of malaria vaccines, Gemma Moncunill and colleagues have linked signatures in the immune system to better vaccine protection from the disease in children and adults.

Passive immunization may slow down SARS-CoV-2 and boost immunity in patients, buying time
The worldwide COVID-19 pandemic has infected more than 4 million people and killed close to 280,000.1 Finding a vaccine has become a global public health priority.

Study results will inform immunization programs globally
The results of the B Part of It study -- the largest meningococcal B herd immunity study ever conducted -- are published today in the New England Journal of Medicine.

Changed route of immunization dramatically improves efficacy of TB vaccine
Tuberculosis (TB), an ancient disease, is the leading infectious cause of death globally, yet the world's only licensed TB vaccine, Bacille Calmette-Guerin (BCG), was developed a century ago.

HPV immunization program cuts pre-cancer rates by more than half
A school-based human papillomavirus (HPV) immunization program in British Columbia, Canada, is dramatically reducing rates of cervical pre-cancer in B.C. women, according to a new study.

Vaccine report calls for innovative transformation strategies to increase influenza immunization rates in underserved communities
Sustainable Healthy Communities announced the publication of a summary report in Vaccine, the leading peer-reviewed journal focused on immunization science, urging health systems, providers and community stakeholders to implement evidence-based strategies to address racial disparities in influenza immunization.

Advantages of DNA immunization platform for eliciting mAbs in multiple species
Researchers have taken advantage of the benefits of DNA immunization over traditional protein-based immunization to elicit monoclonal antibodies (mAbs) against challenging targets in three species -- mouse, rabbit, and human models.

Timing of third-trimester maternal Tdap immunization associated with levels of whooping cough antibodies in newborns
Risk of whooping cough (pertussis) is highest in infants too young to have completed their primary immunization series (6 months old or younger) and they are at highest risk of developing life-threatening complications.

Read More: Immunization News and Immunization Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.